Rebels are right that a £2m rise is pushing it – even for AstraZeneca’s superstar Fund managers tried to vote down Pascal Soriot’s package for fear of more boardroom pay inflation Demonstrators protesting outside AstraZeneca’s Macclesfield offices against its chief executive’s bonus. Photograph: Paul Ellis/AFP/Getty
Nearly 40% of AstraZeneca investors reject boss’s bonus rise. Covid vaccine maker passes its remuneration policy but suffers sizeable rebellion
The Covid-19 vaccine maker saw 38.3% of investors vote against changes that will hike boss Pascal Soriot’s maximum pay deal.